Stockscreener 앱 받기
0.7524
10.52%
-0.0636
시간 외 거래:
.75
-0.00235
-0.31%
전일 마감가:
$0.8159
열려 있는:
$0.815
하루 거래량:
248.49K
Relative Volume:
2.18
시가총액:
$5.60M
수익:
-
순이익/손실:
$-16.28M
주가수익비율:
-0.0541
EPS:
-13.91
순현금흐름:
$-13.75M
1주 성능:
+1.12%
1개월 성능:
-7.65%
6개월 성능:
-47.85%
1년 성능:
-79.83%
1일 변동 폭
$0.70
$0.815
1주일 범위
$0.70
$0.84
52주 변동 폭
$0.65
$4.35
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
명칭
Pasithea Therapeutics Corp
전화
(702) 514-4174
주소
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
KTTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7524 | 6.07M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.77 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.84 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.74 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pasithea Therapeutics Corp 주식(KTTA)의 최신 뉴스
Multi factor analysis applied to Pasithea Therapeutics Corp.Stop Loss & Fast Gaining Stock Strategy Reports - newser.com
Real time social sentiment graph for Pasithea Therapeutics Corp. Equity WarrantQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Pasithea activates new clinical trial site for NF1 treatment study - Investing.com
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients - Investing News Network
Pasithea Therapeutics Opens New Trial Site for PAS-004 - TipRanks
Pasithea Therapeutics Activates New Clinical Trial Site at UAB for PAS-004 Study in Neurofibromatosis Type 1 Patients - Quiver Quantitative
Pasithea (NASDAQ: KTTA) opens UAB site; enrollment begins in Phase 1/1b PAS-004 NF1 study - Stock Titan
Can Pasithea Therapeutics Corp. Equity Warrant stock beat market expectations this quarterShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
Why retail investors pile into Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Pasithea Therapeutics Corp. stock trend forecastGap Up & Consistent Profit Focused Trading Strategies - newser.com
Will Pasithea Therapeutics Corp. stock outperform tech sector in 20252025 Institutional Moves & Weekly High Potential Alerts - newser.com
Can Pasithea Therapeutics Corp. stock outperform in 2025 bull marketBull Run & Daily Stock Momentum Reports - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant qualify in momentum factor screeningShare Buyback & AI Enhanced Market Trend Forecasts - newser.com
Does Pasithea Therapeutics Corp. Equity Warrant stock trade at a discount to peers - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock trend forecastMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Comparing Pasithea Therapeutics Corp. Equity Warrant in custom built stock radarsQuarterly Trade Summary & Daily Entry Point Alerts - newser.com
Real time scanner hits for Pasithea Therapeutics Corp. Equity Warrant explainedVolume Spike & Long-Term Safe Investment Plans - newser.com
Custom strategy builders for tracking Pasithea Therapeutics Corp.Market Growth Summary & Real-Time Sentiment Analysis - newser.com
Is it too late to sell Pasithea Therapeutics Corp.Jobs Report & Short-Term Swing Trade Alerts - newser.com
Pasithea Therapeutics Corp. Equity Warrant stock daily chart insightsQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
Pasithea Therapeutics Corp.’s volatility index tracking explainedEntry Point & Verified Momentum Watchlists - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock supported by strong cash flows2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Has Pasithea Therapeutics Corp. formed a bullish divergence2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
Chart based analysis of Pasithea Therapeutics Corp. Equity Warrant trendsJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Understanding Pasithea Therapeutics Corp. Equity Warrant’s price movementEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Backtesting results for Pasithea Therapeutics Corp. Equity Warrant trading strategies2025 Bull vs Bear & Smart Money Movement Alerts - newser.com
Is Pasithea Therapeutics Corp. Equity Warrant stock positioned for long term growth2025 Market Outlook & Momentum Based Trading Signals - newser.com
Will breakout in Pasithea Therapeutics Corp. lead to full recovery2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What institutional flow reveals about Pasithea Therapeutics Corp. Equity Warrant2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Automated trading signals detected on Pasithea Therapeutics Corp. Equity Warrant2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
Is Pasithea Therapeutics Corp. stock cheap compared to fundamentalsEarnings Recap Summary & Daily Stock Momentum Reports - newser.com
What earnings revisions data tells us about Pasithea Therapeutics Corp.Swing Trade & Proven Capital Preservation Tips - newser.com
Is Pasithea Therapeutics Corp. stock a dividend growth opportunityJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Is Pasithea Therapeutics Corp. stock a safe investment in uncertain marketsTreasury Yields & Weekly Market Pulse Updates - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock outperform value stocksJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Pasithea Therapeutics Corp. stock a buy for dividend growthEarnings Risk Report & Low Risk Profit Maximizing Plans - newser.com
Why Pasithea Therapeutics Corp. Equity Warrant stock is trending among retail tradersJuly 2025 Levels & Reliable Breakout Forecasts - newser.com
Has Pasithea Therapeutics Corp. Equity Warrant found a price floorJuly 2025 Action & Community Consensus Picks - newser.com
Will Pasithea Therapeutics Corp. Equity Warrant stock continue dividend increasesMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Short interest data insights for Pasithea Therapeutics Corp.Quarterly Investment Review & Reliable Breakout Forecasts - newser.com
Why Pasithea Therapeutics Corp. stock is favored by top institutionsJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
Pasithea Therapeutics Corp (KTTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pasithea Therapeutics Corp 주식 (KTTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
1.29%
0.56%
자본화:
|
볼륨(24시간):